Key pathways included those related to cancer, MAPK, PI3K-Akt, prolactin, and C-type lectin receptor signaling, as well as pathways associated with hepatitis B, endocrine resistance, toxoplasmosis, and pancreatic cancer. This evidence concerns the gene CLEC4D and pancreatic neoplasm.